Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28309
Title: The state of migraine: An update on current and emerging treatments.
Austin Authors: Ray, Jason C ;Macindoe, Caroline;Ginevra, Michael;Hutton, Elspeth J
Affiliation: Department of Neurology, Alfred Hospital and Monash University, Melbourne, Vic
General Practitioner, Rowville Health, Rowville, Vic
Neurology
Issue Date: 2021
Date: 2021-12
Publication information: Australian journal of general practice 2021; 50(12): 915-921
Abstract: Migraine is a common neurological disorder, affecting one in seven people, and is the second leading cause of disability worldwide. The aim of this article is to summarise the diagnosis, pathophysiology and treatment of migraine. Key to limiting the disability of migraine and progression to chronic migraine is addressing modifiable risk factors, including implementing effective preventive treatment and avoiding overuse of acute treatment. In this article, the authors review strategies for effective acute and preventive treatment of migraine and introduce the new treatments of migraine targeting calcitonin gene-related peptide signalling.
URI: https://ahro.austin.org.au/austinjspui/handle/1/28309
DOI: 10.31128/AJGP-01-21-5807
Journal: Australian Journal of General Practice
PubMed URL: 34845471
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

24
checked on Nov 15, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.